drugset / Trial / NCT02363075

Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia

NCT02363075

Phase 3 Unknown 58 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is to estimate the efficiency at 3 months of dexamfetamine sulphate on the MFI 20 scale in severe fatigue of patients with stabilized gliomas.

Timeline

Start
2013-04
Primary completion
2017-07
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule 30 mg Oral

Indications